New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 20, 2014
08:07 EDTPTXPernix Therapeutics sees FY14 revenue $110M-$120M, consensus $116.87M
Sees FY14 adjusted EBITDA $22M-$24M.
News For PTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 17, 2014
07:41 EDTPTXPernix Therapeutics submits sNDA for TREXIMET use in adolescent patients
Subscribe for More Information
November 11, 2014
09:36 EDTPTXPernix Therapeutics initiated with an Outperform at Avondale
Target $20.
November 10, 2014
08:11 EDTPTXPernix Therapeutics sees FY15 revenue $230M, consensus $214.07M
Sees FY15 adjusted EBITDA $95M.
08:11 EDTPTXPernix Therapeutics backs FY14 revenue $110M-$120M, consensus $116.87M
Sees FY14 adjusted EBITDA $22M-$24M.
08:10 EDTPTXPernix Therapeutics reports Q3 adjusted EPS (2c), consensus 0c
Reports Q3 revenue $31.5M, consensus $28.13M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use